Comparative Effects of Cervicothoracic Junction Mobilization and Thoracic Manipulation in Subachromial Impinegment Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Oct 25, 2023
Trial Information
Current as of July 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatment methods for people with Subacromial Impingement Syndrome, which causes pain in the shoulder area. The study will compare a technique called thoracic manipulation, where quick movements are used on the upper back, with spinal mobilization combined with arm movements. The goal is to see which method helps reduce shoulder pain more effectively.
To participate in this trial, you should be between 18 and 40 years old and have shoulder pain that has been confirmed by specific tests. However, if you have certain medical conditions, like cancer or arthritis, or if your pain is due to other serious issues, you won't be eligible to join. If you decide to take part, you will receive one of the treatment methods and can expect to attend several sessions. This trial is currently recruiting participants, and it offers a chance to contribute to understanding better ways to manage shoulder pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ranging from 18-40
- • Both males and Females
- • Positive Hawkins and Neer's impingement test positive
- • The subjects primarily report unilateral shoulder pain.
- Exclusion Criteria:
- • Patients with diagnosed case of co morbidities such as malignancies, RA, or fracture, that causes bilateral shoulder discomfort.
- • Diagnosed case of cervical radiculopathy, glenohumeral osteoarthritis, and adhesive capsulitis
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Ali raza
Principal Investigator
Riphah International University
Mehreen Mazhar
Principal Investigator
Riphah inernational university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported